Tenor Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-143,758
| Closed | -$1.45M | – | 612 |
|
2022
Q4 | $1.45M | Hold |
143,758
| – | – | 0.03% | 257 |
|
2022
Q3 | $1.43M | Hold |
143,758
| – | – | 0.03% | 334 |
|
2022
Q2 | $1.42M | Hold |
143,758
| – | – | 0.03% | 348 |
|
2022
Q1 | $1.42M | Hold |
143,758
| – | – | 0.03% | 355 |
|
2021
Q4 | $1.42M | Hold |
143,758
| – | – | 0.03% | 353 |
|
2021
Q3 | $1.4M | Hold |
143,758
| – | – | 0.03% | 304 |
|
2021
Q2 | $1.39M | Sell |
143,758
-136,823
| -49% | -$1.32M | 0.03% | 323 |
|
2021
Q1 | $2.73M | Buy |
+280,581
| New | +$2.73M | 0.07% | 201 |
|